Literature DB >> 16054751

Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma.

Sue Rutherford1, Yongtao Yu, Craig A Rumpel, Henry F Frierson, Christopher A Moskaluk.   

Abstract

As genomic deletion in chromosome 6 has been implicated in the pathogenesis of adenoid cystic carcinoma (ACC), we assayed 58 paired normal and tumor samples for loss of heterozygosity (LOH) using 38 microsatellite markers spanning chromosome 6. Genetic loss occurred in 57% of cases, with the greatest loss found within a 10cM region flanked by markers D6S471 and D6S1687. Among the heterogeneous histologic subtypes of salivary gland carcinomas, only salivary duct carcinoma had a similar frequency of deletion in this region. This locus contains two major candidate tumor suppressor genes, PLAGL1 and LATS1. We analyzed the sequence of these genes in clinical samples of ACC, but found no tumor-specific mutations. Analysis of gene expression showed no substantial differences between samples of normal salivary gland and ACC, eliminating the most obvious candidate genes in this locus as tumor suppressors in ACC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054751     DOI: 10.1016/j.canlet.2005.05.049

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  Genetic alterations in salivary gland cancers.

Authors:  Linda X Yin; Patrick K Ha
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

3.  New genetic variants of LATS1 detected in urinary bladder and colon cancer.

Authors:  Mona K Saadeldin; Heba Shawer; Ahmed Mostafa; Neemat M Kassem; Asma Amleh; Rania Siam
Journal:  Front Genet       Date:  2015-01-13       Impact factor: 4.599

4.  Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue.

Authors:  Diana Bell; Yi-Jue Zhao; Pulivarthi H Rao; Randal S Weber; Adel K El-Naggar
Journal:  Head Neck Pathol       Date:  2007-10-26

5.  Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Authors:  Yoshitsugu Mitani; Jie Li; Pulivarthi H Rao; Yi-Jue Zhao; Diana Bell; Scott M Lippman; Randal S Weber; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-08-11       Impact factor: 12.531

6.  Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type.

Authors:  Ana Flávia Costa; Albina Altemani; Hedy Vékony; Elisabeth Bloemena; Florentino Fresno; Carlos Suárez; José Luis Llorente; Mario Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2011-05-04       Impact factor: 6.730

Review 7.  Adenoid cystic carcinoma: clinical and molecular features.

Authors:  Christopher A Moskaluk
Journal:  Head Neck Pathol       Date:  2013-03-05

8.  Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

Authors:  Martin G Dalin; Nora Katabi; Marta Persson; Ken-Wing Lee; Vladimir Makarov; Alexis Desrichard; Logan A Walsh; Lyndsay West; Zaineb Nadeem; Deepa Ramaswami; Jonathan J Havel; Fengshen Kuo; Kalyani Chadalavada; Gouri J Nanjangud; Ian Ganly; Nadeem Riaz; Alan L Ho; Cristina R Antonescu; Ronald Ghossein; Göran Stenman; Timothy A Chan; Luc G T Morris
Journal:  Nat Commun       Date:  2017-10-30       Impact factor: 14.919

9.  Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.

Authors:  Rania Siam; Ryoko Harada; Chantal Cadieux; Robert Battat; Charles Vadnais; Alain Nepveu
Journal:  Mol Cancer       Date:  2009-08-05       Impact factor: 27.401

Review 10.  YAP/TAZ Activation as a Target for Treating Metastatic Cancer.

Authors:  Janine S A Warren; Yuxuan Xiao; John M Lamar
Journal:  Cancers (Basel)       Date:  2018-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.